rs121912429
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PP2PP3_Moderate
The NM_000875.5(IGF1R):c.2216G>A(p.Arg739Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000875.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251474Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135908
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727242
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not provided Uncertain:2
IGF1R: PM5, PS3:Supporting, PS4:Supporting -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 739 of the IGF1R protein (p.Arg739Gln). This variant is present in population databases (rs121912429, gnomAD 0.007%). This missense change has been observed in individual(s) with IGF1R-related condition (PMID: 15928254). ClinVar contains an entry for this variant (Variation ID: 14793). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt IGF1R protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects IGF1R function (PMID: 34074726). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.2216G>A (p.R739Q) alteration is located in exon 11 (coding exon 11) of the IGF1R gene. This alteration results from a G to A substitution at nucleotide position 2216, causing the arginine (R) at amino acid position 739 to be replaced by a glutamine (Q). Based on data from gnomAD, the A allele has an overall frequency of 0.001% (3/251474) total alleles studied. The highest observed frequency was 0.006% (1/16256) of African alleles. This variant was reported in a mother and daughter with intrauterine growth restriction, short stature, and increased IGF-I levels, and the daughter was noted to have intellectual disability (Kawashima, 2005). Another alteration at the same codon, c.2215C>T (p.R739W), has been detected as maternally inherited in two individuals with short stature, microcephaly, increased IGF-I levels, and mental delay; both mothers were also noted to have short stature (Walenkamp, 2019). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Growth delay due to insulin-like growth factor I resistance Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at